Nitroheterocyclic derivatives: privileged scaffold for drug development against Chagas disease

Nenhuma Miniatura disponível

Data

2019-12-01

Orientador

Coorientador

Pós-graduação

Curso de graduação

Título da Revista

ISSN da Revista

Título de Volume

Editor

Tipo

Resenha

Direito de acesso

Resumo

Chagas disease or American trypanosomiasis is a major public health problem in Latin America. Approximately seven million people are currently infected worldwide. Despite the efforts to develop new drugs, only two nitroheterocyclic drugs (nifurtimox and benznidazole) are available for the treatment of Chagas disease, These drugs have been available since the 1970s, and no new drugs have been approved. Due to the lack of alternatives for the treatment of this disease, this review describes recent advances (2013–2019) concerning nitroheterocyclic compounds with activity against T. cruzi parasites, as well as new perspectives for future research.

Descrição

Idioma

Inglês

Como citar

Medicinal Chemistry Research, v. 28, n. 12, p. 2099-2108, 2019.

Itens relacionados

Financiadores

Coleções